- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-1-1-9-1-1-1-mer
- Ligands
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 3 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.7: 35 residues within 4Å:- Chain C: G.381, S.423, G.425, I.426, G.429, L.430, S.433
- Chain D: F.301, E.302, Y.303, S.304, V.305, N.308, M.309, W.312, I.313, A.316, L.317, A.320
- Chain F: Y.10, F.13
- Chain G: Y.10, F.13, F.14, M.17, S.20, A.21, V.24, F.25, L.86, F.90, L.93, L.97
- Chain H: L.97, L.101
13 PLIP interactions:5 interactions with chain D, 3 interactions with chain G, 1 interactions with chain F, 1 interactions with chain H, 3 interactions with chain C- Hydrophobic interactions: D:W.312, D:A.316, D:L.317, G:F.13, G:A.21, G:F.25, F:F.13, H:L.101
- Salt bridges: D:E.302
- pi-Cation interactions: D:F.301
- Hydrogen bonds: C:S.423, C:G.425, C:I.426
POV.8: 28 residues within 4Å:- Chain C: Y.332, V.334, S.335, W.339, T.341, T.362
- Chain E: G.32, F.33, F.35, D.36, V.37, A.38
- Chain L: F.13
- Chain M: Y.10, F.13, F.14, L.93, L.97
- Chain N: Y.10, F.13, F.14, M.17, A.21, F.25, L.86, F.90, L.93, L.97
8 PLIP interactions:3 interactions with chain N, 4 interactions with chain C, 1 interactions with chain M- Hydrophobic interactions: N:F.14, N:M.17, M:Y.10
- Hydrogen bonds: N:Y.10, C:S.335, C:S.335
- pi-Cation interactions: C:Y.332, C:W.339
POV.9: 26 residues within 4Å:- Chain C: D.417, A.419, S.420, F.421, F.422
- Chain D: Y.299, Y.303, F.307, L.311, W.312, I.315, L.319
- Chain E: V.11, V.13, A.14, F.15, A.17, C.18, A.21, V.22, C.25, Y.26, F.29, L.31, R.34
- Ligands: CLR.6
9 PLIP interactions:3 interactions with chain D, 4 interactions with chain C, 2 interactions with chain E- Hydrophobic interactions: D:F.307, C:F.421, C:F.421, C:F.422, E:F.15, E:Y.26
- pi-Cation interactions: D:Y.299, D:Y.303, C:F.421
- 9 x 01: Cladoniamide A
01.10: 15 residues within 4Å:- Chain F: M.53, K.54, I.56, I.57, V.60, F.128
- Chain G: L.133, F.137
- Chain P: N.439, E.440, I.441, T.444, I.795, M.796, L.799
6 PLIP interactions:4 interactions with chain F, 2 interactions with chain P- Hydrophobic interactions: F:F.128, F:F.128, P:E.440, P:I.441
- Hydrogen bonds: F:K.54, F:I.56
01.11: 9 residues within 4Å:- Chain G: M.53, K.54, I.56, I.57, V.60, M.61, F.128
- Chain H: L.133, F.137
5 PLIP interactions:5 interactions with chain G- Hydrophobic interactions: G:K.54, G:I.56, G:F.128
- Hydrogen bonds: G:K.54, G:I.56
01.12: 8 residues within 4Å:- Chain H: M.53, K.54, I.56, I.57, V.60, F.128
- Chain I: L.133, F.137
4 PLIP interactions:4 interactions with chain H- Hydrophobic interactions: H:K.54, H:F.128
- Hydrogen bonds: H:K.54, H:I.56
01.13: 8 residues within 4Å:- Chain I: M.53, K.54, I.56, I.57, V.60, F.128
- Chain J: L.133, F.137
7 PLIP interactions:7 interactions with chain I- Hydrophobic interactions: I:K.54, I:K.54, I:K.54, I:F.128
- Hydrogen bonds: I:K.54, I:I.56, I:I.56
01.14: 8 residues within 4Å:- Chain J: M.53, K.54, I.56, I.57, V.60, F.128
- Chain K: L.133, F.137
5 PLIP interactions:5 interactions with chain J- Hydrophobic interactions: J:K.54, J:F.128, J:F.128
- Hydrogen bonds: J:K.54, J:I.56
01.15: 8 residues within 4Å:- Chain K: M.53, K.54, I.56, I.57, V.60, F.128
- Chain L: L.133, F.137
5 PLIP interactions:5 interactions with chain K- Hydrophobic interactions: K:K.54, K:K.54, K:I.56
- Hydrogen bonds: K:K.54, K:I.56
01.16: 8 residues within 4Å:- Chain L: M.53, K.54, I.56, I.57, V.60, F.128
- Chain M: L.133, F.137
4 PLIP interactions:4 interactions with chain L- Hydrophobic interactions: L:F.128
- Hydrogen bonds: L:K.54, L:I.56, L:I.56
01.17: 8 residues within 4Å:- Chain M: M.53, K.54, I.56, I.57, V.60, F.128
- Chain N: L.133, F.137
4 PLIP interactions:1 interactions with chain N, 3 interactions with chain M- Hydrophobic interactions: N:L.133
- Hydrogen bonds: M:K.54, M:I.56, M:I.56
01.18: 9 residues within 4Å:- Chain E: I.178, F.182
- Chain N: M.53, K.54, I.56, I.57, V.60, F.128
- Chain P: V.721
5 PLIP interactions:4 interactions with chain N, 1 interactions with chain P- Hydrophobic interactions: N:K.54, N:I.56, P:V.721
- Hydrogen bonds: N:K.54, N:I.56
- 1 x WJP: methyl (3R,6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl dihydrogen diphosphate(Non-covalent)
WJP.20: 27 residues within 4Å:- Chain E: I.106, I.109, N.113, L.188, V.191, I.192, I.195
- Chain P: S.538, M.541, K.542, V.545, F.587, L.590, I.594, K.597, S.611, I.612, L.613, F.616, I.617, F.620, I.735, T.738, A.739, L.742
- Ligands: NAG.21, NAG.22
9 PLIP interactions:9 interactions with chain P- Hydrophobic interactions: P:K.542, P:F.587, P:I.594, P:I.617, P:T.738
- Hydrogen bonds: P:I.612, P:L.613
- Salt bridges: P:K.542, P:K.597
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oot, R.A. et al., Inhibitor bound Vo subcomplex from human V-ATPase. To Be Published
- Release Date
- 2025-09-10
- Peptides
- V-type proton ATPase subunit e 1: A
Ribonuclease kappa: B
V-type proton ATPase subunit S1: C
Renin receptor: D
V-type proton ATPase 21 kDa proteolipid subunit: E
V-type proton ATPase 16 kDa proteolipid subunit: FGHIJKLMN
V-type proton ATPase subunit d 1: O
V-type proton ATPase 116 kDa subunit a 4: P
Anti V-ATPase Nanobody 2CAS66: Q - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
eB
fC
oD
pE
bF
cG
gH
hI
iJ
jK
kL
lM
mN
nO
dP
aQ
q - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-1-1-9-1-1-1-mer
- Ligands
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 3 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 9 x 01: Cladoniamide A
- 1 x WJP: methyl (3R,6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl dihydrogen diphosphate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Oot, R.A. et al., Inhibitor bound Vo subcomplex from human V-ATPase. To Be Published
- Release Date
- 2025-09-10
- Peptides
- V-type proton ATPase subunit e 1: A
Ribonuclease kappa: B
V-type proton ATPase subunit S1: C
Renin receptor: D
V-type proton ATPase 21 kDa proteolipid subunit: E
V-type proton ATPase 16 kDa proteolipid subunit: FGHIJKLMN
V-type proton ATPase subunit d 1: O
V-type proton ATPase 116 kDa subunit a 4: P
Anti V-ATPase Nanobody 2CAS66: Q - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
eB
fC
oD
pE
bF
cG
gH
hI
iJ
jK
kL
lM
mN
nO
dP
aQ
q - Membrane
-
We predict this structure to be a membrane protein.